GlassScriptPhysician profile
Heidi Biggs
NPI 1205499118
$830.80
in general payments reported to CMS, 2019-2025
14 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.70 · 2023: $155 · 2024: $359 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $267.73 | 2023-2025 | Inspire |
| Lilly USA, LLC | $127.60 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.34 | 2021-2024 | Tradjenta, Synjardy, Trijardy Xr |
| Exact Sciences Corporation | $83.41 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abiomed | $49.87 | 2023-2024 | Impella |
| Eisai INC. | $41.75 | 2021-2024 | |
| Novo Nordisk INC | $38.50 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $29.83 | 2025 | Breztri |
| Pfizer INC. | $22.14 | 2024 | |
| Phathom Pharmaceuticals, INC. | $20.92 | 2025 | Voquezna |
| Amgen INC. | $17.13 | 2024 | Evenity, Prolia |
| Glaxosmithkline, LLC. | $16.33 | 2023 | Arexvy, Shingrix |
| Dexcom, INC. | $15.43 | 2024 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Biggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.